Market closedNon-fractional
VolitionRX/VNRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About VolitionRX
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Ticker
VNRX
Sector
Healthcare
Trading on
AMEX
Industry
Health Care Equipment and Supplies
Headquarters
Henderson, United States
Employees
108
Website
www.volition.com
VolitionRX Metrics
BasicAdvanced
$51M
Market cap
-
P/E ratio
-$0.46
EPS
1.26
Beta
-
Dividend rate
Price and volume
Market cap
$51M
Beta
1.26
Financial strength
Current ratio
0.428
Quick ratio
0.378
Long term debt to equity
-24.961
Total debt to equity
-33.378
Interest coverage (TTM)
-142.72%
Management effectiveness
Return on assets (TTM)
-117.82%
Return on equity (TTM)
359.94%
Valuation
Price to revenue (TTM)
59.65
Price to book
-3.26
Price to tangible book (TTM)
-3.21
Price to free cash flow (TTM)
-2.553
Growth
Revenue change (TTM)
133.06%
Earnings per share change (TTM)
-17.47%
3-year revenue growth
174.77%
3-year earnings per share growth
1.75%
What the Analysts think about VolitionRX
Analyst Ratings
Majority rating from 3 analysts.
VolitionRX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$100K
-50.00%
Net income
-$8.3M
-3.49%
Profit margin
-8,300.00%
93.02%
VolitionRX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.14
-$0.11
-$0.11
-$0.10
-
Expected
-$0.15
-$0.13
-$0.11
-$0.11
-$0.10
Surprise
-5.08%
-15.38%
3.12%
-9.09%
-
VolitionRX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for VolitionRX stock?
VolitionRX (VNRX) has a market cap of $51M as of July 06, 2024.
What is the P/E ratio for VolitionRX stock?
The price to earnings (P/E) ratio for VolitionRX (VNRX) stock is 0 as of July 06, 2024.
Does VolitionRX stock pay dividends?
No, VolitionRX (VNRX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next VolitionRX dividend payment date?
VolitionRX (VNRX) stock does not pay dividends to its shareholders.
What is the beta indicator for VolitionRX?
VolitionRX (VNRX) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell VolitionRX stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell VolitionRX stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.